BioLineRx seeks therapeutic projects at all stages in the development process. In order to achieve the highest chances of success, BioLineRx employs a stringent screening process using clear economic, scientific and medical metrics.

BioLineRx welcomes project submissions that can meet the following criteria:

•	Scientific / Medical Innovation: Projects focused on innovative therapies (not diagnostics or devices) that provide unique solutions and/or significant improvements over existing and available medical treatments.
•	Market Potential: Projects addressing unmet medical needs that can lead to significant end-product sales.
•	Competitive Advantage: Technologies and applications that provide a sustainable edge over existing and potential alternative treatments.
•	Proof-of-Principle: Solutions at any stage of the development process, including feasibility, preclinical or even clinical, with an emphasis on proof of principle.
•	Clinical Data : High quality clinical data from well planned and administered safety and efficacy trials.
•	Team Expertise & Motivation: A high caliber scientific team with strong drive to see their dreams brought to fruition and their inventions and methods applied and commercialized.
•	Rich IP Base: A rich intellectual property base, either existing or potential, that can provide the necessary protection for sales of resulting products.